Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients

Journal of Nuclear Medicine

Volumn 39, Issue 8 SUPPL., 1998, Pages 1366-1369

  Lorberboym, Mordechai ^a,b   Wallach, Fran ^a,b   Estok, Lois ^a,b   Mosesson, Roger E ^a,b   Sacher, Michael ^a,b   Kim, Chun K ^a,b   Machac, Josef ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Acquired immunodeficiency syndrome; Central nervous system lymphoma; Retention index; Thallium 201; Toxoplasmosis

Indexed keywords

THALLIUM 201;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN BIOPSY; BRAIN LYMPHOMA; BRAIN METASTASIS; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RADIATION INJURY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TOXOPLASMOSIS; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BRAIN; BRAIN DISEASES; CENTRAL NERVOUS SYSTEM NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOXOPLASMOSIS, CEREBRAL;

EID: 0031829228     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. 201'II SPECI J Nucl Med 1996:37: 1150-1154.
2. Cincillo SK Rosenhluni Ml ('se ol'CT aiul MR to distinguish inttacraniül lesions and to define the need lor hiopsv in AIDS patienls. SPECI J Nucl Med 1996:37: 724
3. Kupfer MC. Zee CS. Collelli PM. Hoswell WD. Rhodes R 11. VIRI exaliialion of AIDS-relaied eneephalopath>': toxoplasmosis vs lymplionui SPECI J Nucl Med 1996:37: 1990;8:51-57
4. 201 SI quanlitate malignancy grade of gliomas J Neurosurg 1989;71:342-346
5. Hodges JR. Warlow CP. The aetiology of transient global amnesia: a case-confol study of 114 cases with prospective follow-up. Brain 1990;! 13:639-657.
6. Frederiks JAM. Transient global amnesia. Clin Nenrol Neurosurg 1993:95:265-2 3.
7. Melo TP. Ferro JM, Ferro H. Transient global amnesia: a case control study. Bn'in 1992:115:261-270.
8. Stillhard G, tandis T. Schiess R. Regard M, Sialcr G. Bitemporal hypoperfusion in transient global amnesia: 99m-Tc-HM-PAO SPECT and neuropsychological findings during and after an attack.,/ \eurol Neurosurg Psychiatry 1990:53:339-342.
9. Goldenberg G. Podrcka I. Pfaffelmeyer N, Wessely P, Deecke L. Thalamic ischemia in transient global amnesia: a SPECT study. Neurology 1991:41:1748-1752.
10. Tanabe H, Hashikawa K. Nakagawa Y, et al. Memory loss due to transient hypoperfusion in the medial temporal lobes including hippocampus. Ada Neutol Stand 1991:84:22-27.
11. Lin KN, Liu RS. Yeh TP, Wang S.I. Liu HC. Posterior ischemia during an attack of transient global amnesia. Stroke 1993:24:1093-1095.
12. Hodges JR. Semantic memory and frontal executive function during transient glotal amnesia. ./ Neural Neurosurg Psychiatry 1994:57:605-608.
13. Nakagauara J. Nakamura J, Takeda R, et al. Assessment of postischemic reperfusion and diamox activation test in stroke using <|!)nlTc-ECD SPECT. J Cereb Blood Fit H' Mctah 1994:14(suppl l ):S49 S57.
14. Ishizu K. Yonekura Y. Magata Y, et al. Extraction and retention of technetium-99rnECD in human brain: dynamic SPECT and oxygen-15-water PET studies. J Nucl Med 1996:37:1600-1604.
15. Friberg E. Andersen AR. Lassen NA, Holm S, Dam M. Retention of'''Tc-bicisate in the human brain after intracarotid injection. J Cereb Blood Flow Metab 1994;14(suppl U-.S19-S27.
16. Takeuchi R. Matsuda H, Yonekura Y, Sakahara H. Konishi J. Noninvasive quantitatie measurements of regional cerebral blood flow using technetium-99m-L,L,-ECD SPECT activated with acetazolamide. Quantification analysis by equal-volume-sp it Tc-F.CD consecutive SPECT method. J Cereb Blond Flo- Metab 1997:17:102C1032.
17. Matsuda H. Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K. A quantitative approach to technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Mtd 1992:19:195 200.
18. Matsuda H. Yagishita A. Tsuji S, Hisada K. A quantitative approach to technetium99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropyler e amine oxime. Eur J \ucl Med 1995:22:633- 637.
19. Lassen NA. Andersen AR, Friberg L, Paulson OB. The retention of ['Tc]-o',/,HM-PAO in the human brain after intraearotid bolus injection: a kinetic analysis. J Ci'ivh Blood Flow Metab 1988:8(suppl 1):S13 -S22.
20. Baron JC. Bousser MG. Rey A, Guillard A, Comar D. Castaigne P. Reversal of focal misery-perfusion syndrome by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with O positron emission tomography. Stroke 1981:12:454-459.
21. Gibbs JM. Wise RJS. Lcenders KL. Jones T. Evaluation of cerebral perfusion reservein patients with carotid-artery occlusion. Lancet 19K4;11:310-314.
22. Pozzzilli C'. Passafiume D. Bernard! S. SPECT. MRI and cognitive functions in multiple sclerosis. J Neurnl ArHrasiirt,' Psychiatry 1991:54:1 10-1 15.
23. Kao CH. Lan .IL. ChangLai SP. Chieng PU. Tcchnetium-99m HMPAO brain SPECT in Sjogren's syndrome.. Mecl 1998:39:773 777.
24. Nishimura H. Tachibana H. Makiura N. Okuda B. Sugita M. C'orlicosteroid-responsi' e parkinsonism associated with primary Sjogren's syndrome. Clin enrnl eurosnr 1994:96:327-331.
25. Gerraty RP. McKelvie PA. Bynie E. Aseptic meningocneephalitis in primary Sjogren's syndrome. Response to plasmapheresis and absence of CNS vasculitis at autopsy. Ac u Neurnl Scand 1993:88:309 311.
26. Herman JL. Kashii S. Trachtman MS. Burde RM. Optic neuropathy and ccntnl nervous system disease secondary to Sjogren's syndrome in a child. Ophtliiil/uulot'Y 1990:97:1606-1609.
27. de-la-Monte SM. Hutchins GM. Ciupta PK. Polymorphous meningitis with atypicil mononuclear cells in Sjogren's syndrome. Ann Neurol 1983:14:455 -461.
28. Alexander EL. Provost 'IT. Stevens MB. Alexander GE. Neurologic complications of primary Sjogren's syndrome. Medicine 1982:61:247-257.
29. Grunwald F. Schomburg A. Badali A. Ruhlmann J. Pavics L. Biersack HJ. 1SFDG PET and acetazolamide-enhanced Tc-HMPAO SPECT in systemic lupus erythematosin. Eur J itcl Med 1995:22:1073 1077.
30. Sana CiB. Maeintyrc WJ. Brunken RC', et al. Present assessment of myocardial iability by nuclear medicine. Semin Xttcl Med 1996:26:315 335.